Dr. Reddy's Laboratories RDY
Valuation
Multiples measured against the stock's own five-year history
Near the top of its 5-year range · 99th percentile, 5-year average 22.6x
#2444 of 2994 stocks by PE (1 = cheapest)
Below its usual level · 25th percentile, 5-year average 3.5x
#3745 of 5331 stocks by PB (1 = cheapest)
Above its usual level · 72nd percentile, 5-year average 3.4x
#3457 of 5155 stocks by PS (1 = cheapest)
P/E over five years
Dashed line is the 5-year average; the shaded band is one standard deviation either side.
Morningstar fair value estimate
| Multiple | Current | Forward | 5y average | Percentile vs. own history | Industry rank |
|---|---|---|---|---|---|
| PB | 2.99 | – | 3.47 | 25% (cheaper than usual) | #3745 of 5331 (1 = cheapest) |
| PE | 41.29 | 27.03 | 22.59 | 99% (pricier than usual) | #2444 of 2994 (1 = cheapest) |
| PS | 3.51 | 3.07 | 3.42 | 72% (pricier than usual) | #3457 of 5155 (1 = cheapest) |
Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.
No comments yet — be the first to weigh in on RDY.
Sign in to join the discussion.